首页 | 本学科首页   官方微博 | 高级检索  
检索        

刺五加注射液联合前列地尔治疗4期糖尿病肾病
引用本文:盖云,张彤.刺五加注射液联合前列地尔治疗4期糖尿病肾病[J].中国临床医学,2011,18(4):535-537.
作者姓名:盖云  张彤
作者单位:上海市第七人民医院中医科,上海,200137
基金项目:上海市浦东新区卫生局资助项目(编号:PWZ2008-21-k01)
摘    要:目的:观察刺五加注射液联合前列地尔治疗4期糖尿病肾病的临床疗效。方法:对70例4期糖尿病肾病病例分为研究组(35例)与对照组(35例)。对照组给予常规疗法控制血糖、血压,同时采用前列地尔静脉滴注。研究组在对照组用药基础上加用刺五加注射液静脉滴注,2周后观察2组临床疗效、24h尿蛋白定量、血清肌酐、血液流变学等指标的变化情况。结果:治疗后研究组与对照组中医症候疗效分别为82.86%和48.57%(P〈0.05),西医临床疗效分别为57.14%和29.63%(P〈0.05)。研究组治疗后24h尿蛋白量、血肌酐明显降低(P〈0.05)。2组治疗前患者血液流变学无显著差异;治疗后研究组指标优于对照组,差异有统计学意义(P〈0.05)。结论:刺五加注射液联合前列地尔结合西医常规疗法能够减少糖尿病肾病患者的尿蛋白排泄、改善肾功能,有望延缓4期糖尿病肾病进入终末期肾病的进程。

关 键 词:糖尿病肾病4期  刺五加注射液  前列地尔  中西医结合疗法

Clinical Study on the Effect of Acanthopanex Injection Combined with Liposomal Alprostadil in the Treatment of Stage-IV Diabetic Nephropathy
GAI Yun,ZHANG Tong.Clinical Study on the Effect of Acanthopanex Injection Combined with Liposomal Alprostadil in the Treatment of Stage-IV Diabetic Nephropathy[J].Chinese Journal Of Clinical Medicine,2011,18(4):535-537.
Authors:GAI Yun  ZHANG Tong
Institution:Department of TCM,the Seventh People′s Hospital,Shanghai 200137,China
Abstract:Objective:To study the effect of Acanthopanex Injection combined with liposomal alprostadil(Lipo-PG E1) in the treatment of stage-IV diabetic nephropathy.Methods: A Prospective comparative study method was utilized in this clinical trial.70 diagnosed cases were divided into groups,study group(35 cases) and control group(35cases).On the base controlling of blood glucose and pressure,the control group were injected liposomal alprostadi,while the the study group were injected Acanthopanex Injection combined wi...
Keywords:Stage-Ⅳ diabetic nephropathy  Acanthopanex injection  Liposomal alprostadil  Integrated TCM-WM therapy
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号